Federal Register / Vol. 62, No. 175 / Wednesday, September 10, 1997 / Notices 47675

Time: 8:30 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Gavin T. Wilkom,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4868.

Committee Name: Neuropharmacology and

Neurochemistry Review Committee.

Date: October 9–October 10, 1997.

Time: 8:30 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Ave, Chevy Chase, MD 20815.

Contact Person: Donna Ricketts, Parklawn,

Room 9–01, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301, 443–3936.

Committee Name: Molecular, Cellular, and

Developmental Neurobiology Review

Committee.

Date: October 13–October 14, 1997.

Time: 8:30 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Ave, Chevy Chase, MD 20815.

Contact Person: Donna Ricketts, Parklawn,

Room 9–01, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301, 443–3936.

Committee Name: Services Research

Review Committee.

Date: October 14–October 15, 1997.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gavin T. Wilkom,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4868.

Committee Name: Psychobiology,

Behavior, and Neuroscience Review

Committee.

Date: October 16–October 17, 1997.

Time: 9 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Deborah A. DeMasse,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

3936.

Committee Name: Perception and

Cognition Review Committee.

Date: October 16–October 17, 1997.

Time: 8:30 a.m.

Place: Wyndham Bristol Hotel, 2430

Pennsylvania Ave., N.W., Washington, DC

20037.

Contact Person: Regina M. Thomas,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

6470.

Committee Name: Cognitive Functional

Neuroscience Review Committee.

Date: October 16–October 17, 1997.

Time: 8:30 a.m.

Place: One Washington Circle, One

Washington Circle, N.W., Washington, DC

20037.

Contact Person: Shirley H. Maltz,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

3936.

Committee Name: Clinical Centers and

Special Projects Review Committee.

Date: October 20–October 21, 1997.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4868.

Committee Name: Health Behavior and

Prevention Review Committee.

Date: October 20–October 21, 1997.

Time: 8:30 a.m.

Place: St. James Hotel, 950 24th Street,

N.W., Washington, DC 20037.

Contact Person: Monica F. Woodfork,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4843.

Committee name: Clinical Neuroscience

and Biological Psychopathology Review

Committee.

Date: October 22–October 24, 1997.

Time: 9 a.m.

Place: Avenue Plaza Hotel, 2111 St.

Charles Avenue, New Orleans, LA 70130.

Contact person: Maureen L. Eister,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

3936.

Committee name: Treatment Assessment

Review Committee.

Date: October 23–October 24, 1997.

Time: 8:30 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact person: Gavin T. Wilkom,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4868.

Committee name: Violence and Traumatic

Stress Review Committee.

Date: October 23–October 24, 1997.

Time: 8:30 a.m.

Place: Latham Hotel, 3000 M Street, N.W.,

Washington, DC 20007.

Contact person: Sheri L. Schwartzback,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

4843.

Committee name: Child/Adolescent

Development, Risk, and Prevention Review

Committee.

Date: October 23–October 24, 1997.

Time: 9 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact person: Phyllis D. Artis, Parklawn,

Room 9C–26, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301, 443–6470.

Committee name: Child Psychopathology

and Treatment Review Committee.

Date: October 27–October 28, 1997.

Time: 8:30 a.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact person: Richard Johnson,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

1367.

Committee name: Social and Group

Processes Review Committee.

Date: November 6–November 7, 1997.

Time: 8:30 .m.

Place: The George Washington University

Inn, 824 New Hampshire Avenue, N.W.,

Washington, DC 20037.

Contact person: Rehana A. Chowdhury,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

6470.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers 93.242, 93.281, 93.282)

Dated: September 4, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–23892 Filed 9–9–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of

Meeting of the National Advisory Child

Health and Human Development

Council and Its Subcommittee on

Planning and Policy

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the National Advisory Child Health and

Human Development Council on

September 22–23, 1997. The meeting

will be held in Building 31, Conference

Room 10, National Institutes of Health,

Bethesda, Maryland. The Subcommittee

on Planning and Policy will be held on

September 22, 1997, in Building 31,

Room 2A03, from 8:00 a.m. to 9:30 a.m.

The Subcommittee meeting will be open

to the public and the agenda includes

program plans and the agenda for the

next Council meeting. Attendance by

the public will be limited to space

available.

The Council meeting will be open to

the public in September 22 from 10:00

a.m. until 5:30 p.m. The agenda

includes reports by the Director, NICHD,

and the National Center for Medical

Rehabilitation Research, a presentation

by the Scientific Director, NICHD, and

other business of the Council. The

meeting will be open on September 23

upon completion of the review of

applications at approximately 1:00 p.m.

to adjournment if any policy issues are

raised which need further discussion.

In accordance with the provisions set

forth in sections 522b(c)(4) and

552b(c)(6), Title 5, United States Code

and section 10(d) of Public Law 92–463,

the meeting of the full Council will be

closed to the public on September 23
47676 Federal Register / Vol. 62, No. 175 / Wednesday, September 10, 1997 / Notices

from 8:00 a.m. to approximately 1:00

p.m. for the review, discussion, and

evaluation of individual grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Ms. Mary Plummer, Executive

Secretary, NACHHD Council, 6100

Executive Boulevard, Room 5E03,

National Institutes of Health, Bethesda,

Maryland 20892–7510, Area Code 301,

594–7232, will provide a summary of

the meeting and a roster of Council

members as well as substantive program

information. Individuals who plan to

attend the open session and need

special assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Plummer.

(Catalog of Federal Domestic Assistance

Program Nos. [93.864, Population Research,

and 93.865, Research for Mothers and

Children], National Institutes of Health)

Dated: September 4, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–23893 Filed 9–9–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Amended Notice of Meeting of the

National Deafness and Other

Communication Disorders Advisory

Council

Notice is hereby given of a change in

the September 11 meeting of the

National Deafness and Other

Communication Disorders Advisory

Council which was published on

August 7, 1997, 62 FR 42587.

The meeting was to have been a

closed meeting convened at 1 pm and

adjourned at 2 pm on September 11.

The meeting has been changed to a

partially closed meeting. The Council

will meet in open session from 1 pm to

approximately 1:45 pm to discuss a

meeting of the Work Group on Peer

Review. At approximately 1:45 pm the

meeting will be closed until

adjournment for the review of grant

applications.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: September 4, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–23896 Filed 9–9–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Natiional Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date of Meeting: September 12, 1997.

Time: 8:30 a.m. to adjournment.

Place of Meeting: Holiday Inn, 5520

Wisconsin Avenue, Bethesda, MD 20815.

Contact Person: Elsie Taylor, 6000

Executive Boulevard, Suite 409, Rockville,

MD 20892–7003, 301–443–9787.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

proposal and discussions could reveal

confidential trade secrets or commercial

property such as patentable material, and

personal information concerning individuals

associated with the proposal, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

(Catalog of Federal Domestic Assistance,

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants;

National Institutes of Health)

Dated: September 4, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–23898 Filed 9–9–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: For Nucleic Acid-Based

Vaccines and Therapeutics

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This is a notice in accordance

with 35 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(i) that the National Institutes

of Health (NIH), Department of Health

and Human Services, is contemplating

the grant of a limited field of use

exclusive license in the United States to

practice the invention embodied in U.S.

Patent Application Number 08/286,730

entitled, ‘‘Liposomal Delivery System

for Nucleic Acids,’’ and its

Continuation-In-Part U.S. Patent

Application Serial Number 08/522,246,

and all related foreign filings (PCT/

US95/09867), invented by Alain Thierry

formerly of the National Cancer

Institute, to Biovector Therapeutics, S.A

of Labage, France. The patent rights in

these inventions have been assigned to

the United States of America.

DATES: Only written comments and/or

applications for a license which are

received by NIH on or before December

9, 1997 will be considered.

ADDRESSES: Requests for copies of the

subject issued patent and pending

patent applications, inquiries,

comments and other materials relating

to the contemplated license should be

directed to: Mr. Larry M. Tiffany, Office

of Technology Transfer, National

Institutes of Health, 6011 Executive

Boulevard, Suite 325, Rockville, MD

20852; Telephone: (301) 496–7056, ext.

206; Facsimile: (301) 402–0220. A

signed Confidentiality Agreement will

be required to receive copies of the

pending patent applications.

SUPPLEMENTARY INFORMATION: The

present invention relates to a liposome

composition comprising a bi- or multilayered membrane surrounding an

internal aqueous liposome comprising

at least one cationic lipopolyamine and

at least one neutral lipid provided in a

molar ratio range, said ratio from about

.02:1 to 2:1. In addition to the pending

composition claims there are also

pending rights to methods of preparing

the liposome composition,

pharmaceutical compositions including

the liposome and methods of

introducing nucleic acids into cells

using the liposome. This invention is

advantageous over alternative lipid

preparations due to its ability to more